Form 4: Kingstone Companies Grants Equity Awards to Chief Actuary and Senior VP Minlei Chen

Sentiment:

Insider Transaction Report


Minlei Chen, Chief Actuary and Senior VP of Kingstone Companies, Inc., was granted 10,000 shares of common stock and holds stock options, increasing their beneficial ownership.

Summary

  • Minlei Chen, Chief Actuary and Senior VP of Kingstone Companies, Inc. (KINS), acquired 10,000 shares of common stock on June 18, 2025, through a restricted stock grant at a price of $0 per share.
  • Following this transaction, Minlei Chen beneficially owns a total of 29,340 shares of common stock.
  • The total beneficial ownership includes 13,956 shares received pursuant to an unvested restricted stock grant, which will vest in tranches: 3,645 shares on March 3, 2026; 3,333 shares on June 18, 2026; 3,645 shares on March 3, 2027; and 3,333 shares on June 18, 2027.
  • Minlei Chen also holds stock options for 10,000 shares of common stock with an exercise price of $2.25 per share, expiring on January 5, 2029.
  • The stock options vest in tranches: 3,334 shares on January 5, 2025; 3,333 shares on January 5, 2026; and 3,333 shares on January 5, 2027.

Sentiment

Score: 7

Explanation: The grant of equity awards to a senior executive is generally viewed positively as it aligns management's interests with shareholders, though it's a routine compensation event and not indicative of extraordinary performance or strategic shifts.

Positives

  • The grant of restricted stock and stock options aligns the interests of Chief Actuary and Senior VP Minlei Chen with those of shareholders, as their compensation is tied to the company's future performance.
  • Increased insider ownership can signal confidence in the company's long-term prospects.

Future Outlook

The document details future vesting schedules for restricted stock and stock options, indicating a long-term incentive structure for the executive through January 2029.

Industry Context

This Form 4 filing is a routine disclosure of an executive's equity compensation, common across all industries, including the insurance sector where Kingstone Companies operates. It does not provide broader industry trends or competitive analysis.

Related Party Transactions

  • The document details an equity grant from Kingstone Companies, Inc. to Minlei Chen, a senior executive (Chief Actuary and Senior VP), which is a transaction between the company and a related party.

Stakeholder Impact

  • Shareholders: The equity grant aims to align the interests of a key executive with shareholder value, potentially leading to improved long-term performance.
  • Employees: This filing specifically pertains to executive compensation and does not directly impact the broader employee base.

Next Steps

  • Vesting of 3,334 stock options on January 5, 2025.
  • Vesting of 3,333 stock options on January 5, 2026.
  • Vesting of 3,645 unvested restricted shares on March 3, 2026.
  • Vesting of 3,333 unvested restricted shares on June 18, 2026.
  • Vesting of 3,333 stock options on January 5, 2027.
  • Vesting of 3,645 unvested restricted shares on March 3, 2027.
  • Vesting of 3,333 unvested restricted shares on June 18, 2027.
  • Expiration of stock options on January 5, 2029.

Key Dates

DateDescription
01/05/2025First tranche of stock option (3,334 shares) vests and becomes exercisable.
06/18/2025Date of common stock acquisition (restricted stock grant) for 10,000 shares.
06/20/2025Date the Form 4 was signed by Minlei Chen.
01/05/2026Second tranche of stock option (3,333 shares) vests and becomes exercisable.
03/03/2026First tranche of unvested restricted stock (3,645 shares) vests.
06/18/2026Second tranche of unvested restricted stock (3,333 shares) vests.
01/05/2027Third tranche of stock option (3,333 shares) vests and becomes exercisable.
03/03/2027Third tranche of unvested restricted stock (3,645 shares) vests.
06/18/2027Fourth tranche of unvested restricted stock (3,333 shares) vests.
01/05/2029Expiration date for the stock options.

Keywords

Kingstone Companies, KINS, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock, Stock Option, Executive Compensation, Minlei Chen

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.